| The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology AC Liu, VR Joag, AI Gotlieb The American journal of pathology 171 (5), 1407-1418, 2007 | 829 | 2007 |
| Proteolytic processing of Nlrp1b is required for inflammasome activity BC Frew, VR Joag, J Mogridge PLoS pathogens 8 (4), e1002659, 2012 | 180 | 2012 |
| Cutting edge: nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity WE Matchett, V Joag, JM Stolley, FK Shepherd, CF Quarnstrom, ... The Journal of Immunology 207 (2), 376-379, 2021 | 148 | 2021 |
| T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers PS Arunachalam, TP Charles, V Joag, VS Bollimpelli, MKD Scott, ... Nature medicine 26 (6), 932-940, 2020 | 142 | 2020 |
| Retrograde migration supplies resident memory T cells to lung-draining LN after influenza infection JM Stolley, TS Johnston, AG Soerens, LK Beura, PC Rosato, V Joag, ... Journal of Experimental Medicine 217 (8), e20192197, 2020 | 114 | 2020 |
| Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes A Sivro, A Schuetz, D Sheward, V Joag, S Yegorov, LJ Liebenberg, ... Science translational medicine 10 (425), eaam6354, 2018 | 97 | 2018 |
| Identification of preferential CD4+ T-cell targets for HIV infection in the cervix VR Joag, LR McKinnon, J Liu, ST Kidane, MH Yudin, B Nyanga, ... Mucosal immunology 9 (1), 1-12, 2016 | 97 | 2016 |
| Inflammation and HIV transmission in sub-Saharan Africa R Kaul, J Prodger, V Joag, B Shannon, S Yegorov, R Galiwango, ... Current HIV/AIDS Reports 12, 216-222, 2015 | 79 | 2015 |
| Impact of standard bacterial vaginosis treatment on the genital microbiota, immune milieu, and ex vivo human immunodeficiency virus susceptibility V Joag, O Obila, P Gajer, MC Scott, S Dizzell, M Humphrys, K Shahabi, ... Clinical Infectious Diseases 68 (10), 1675-1683, 2019 | 70 | 2019 |
| Rapid autocatalytic activation of the M4 metalloprotease aureolysin is controlled by a conserved N‐terminal fungalysin‐thermolysin‐propeptide domain NN Nickerson, V Joag, MJ McGavin Molecular microbiology 69 (6), 1530-1543, 2008 | 63 | 2008 |
| Cutting edge: mouse SARS-CoV-2 epitope reveals infection and vaccine-elicited CD8 T cell responses V Joag, S Wijeyesinghe, JM Stolley, CF Quarnstrom, T Dileepan, ... The Journal of Immunology 206 (5), 931-935, 2021 | 44 | 2021 |
| Impact of endemic infections on HIV susceptibility in sub-Saharan Africa S Yegorov, V Joag, RM Galiwango, SV Good, B Okech, R Kaul Tropical Diseases, Travel Medicine and Vaccines 5, 1-18, 2019 | 27 | 2019 |
| Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways S Yegorov, V Joag, RM Galiwango, SV Good, J Mpendo, E Tannich, ... Nature communications 10 (1), 1-12, 2019 | 27 | 2019 |
| Tissue-resident memory T cells trigger rapid exudation and local antibody accumulation PC Rosato, S Lotfi-Emran, V Joag, S Wijeyesinghe, CF Quarnstrom, ... Mucosal immunology 16 (1), 17-26, 2023 | 18 | 2023 |
| Characterization of CD4+ T cell subsets and HIV susceptibility in the inner and outer foreskin of Ugandan men RM Galiwango, S Yegorov, V Joag, J Prodger, K Shahabi, S Huibner, ... American Journal of Reproductive Immunology 82 (1), e13143, 2019 | 14 | 2019 |
| Depleting CD103+ resident memory T cells in vivo reveals immunostimulatory functions in oral mucosa JM Stolley, MC Scott, V Joag, AJ Dale, TS Johnston, F Saavedra, ... Journal of Experimental Medicine 220 (7), e20221853, 2023 | 11 | 2023 |
| Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data SM Hughes, CN Levy, R Katz, EM Lokken, MN Anahtar, MB Hall, ... BMC medicine 20 (1), 353, 2022 | 10 | 2022 |
| Protocol for a randomized clinical trial exploring the effect of antimicrobial agents on the penile microbiota, immunology and HIV susceptibility of Ugandan men RM Galiwango, B Bagaya, J Mpendo, V Joag, B Okech, A Nanvubya, ... Trials 20, 1-9, 2019 | 9 | 2019 |
| Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women V Joag, A Sivro, N Yende-Zuma, H Imam, N Samsunder, Q Abdool Karim, ... PLoS One 13 (7), e0200359, 2018 | 8 | 2018 |
| Treatment success following standard antibiotic treatment for bacterial vaginosis is not associated with pretreatment genital immune or microbial parameters E Armstrong, A Hemmerling, V Joag, S Huibner, M Kulikova, E Crawford, ... Open forum infectious diseases 10 (1), ofad007, 2023 | 6 | 2023 |
